Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 351

1.

A perioperative multidisciplinary care bundle reduces surgical site infections in patients undergoing synchronous colorectal and liver resection.

Tufts LS, Jarnagin ED, Flynn JR, Gonen M, Guillem JG, Paty PB, Nash GM, Smith JJ, Wei IH, Pappou E, D'Angelica MI, Allen PJ, Peter Kingham T, Balachandran VP, Drebin JA, Garcia-Aguilar J, Jarnagin WR, Weiser MR.

HPB (Oxford). 2018 Aug 1. pii: S1365-182X(18)32686-8. doi: 10.1016/j.hpb.2018.07.001. [Epub ahead of print]

PMID:
30077525
2.

Effectiveness of a multidisciplinary patient care bundle for reducing surgical-site infections.

Weiser MR, Gonen M, Usiak S, Pottinger T, Samedy P, Patel D, Seo S, Smith JJ, Guillem JG, Temple L, Nash GM, Paty PB, Baldwin-Medsker A, Cheavers CE, Eagan J, Garcia-Aguilar J; Memorial Sloan Kettering Multidisciplinary Surgical-Site Infection Reduction Team.

Br J Surg. 2018 Jul 4. doi: 10.1002/bjs.10896. [Epub ahead of print]

PMID:
29974946
3.

Integrated molecular subtyping defines a curable oligometastatic state in colorectal liver metastasis.

Pitroda SP, Khodarev NN, Huang L, Uppal A, Wightman SC, Ganai S, Joseph N, Pitt J, Brown M, Forde M, Mangold K, Xue L, Weber C, Segal JP, Kadri S, Stack ME, Khan S, Paty P, Kaul K, Andrade J, White KP, Talamonti M, Posner MC, Hellman S, Weichselbaum RR.

Nat Commun. 2018 May 4;9(1):1793. doi: 10.1038/s41467-018-04278-6.

4.

Poorly Differentiated Clusters Predict Colon Cancer Recurrence: An In-Depth Comparative Analysis of Invasive-Front Prognostic Markers.

Konishi T, Shimada Y, Lee LH, Cavalcanti MS, Hsu M, Smith JJ, Nash GM, Temple LK, Guillem JG, Paty PB, Garcia-Aguilar J, Vakiani E, Gonen M, Shia J, Weiser MR.

Am J Surg Pathol. 2018 Jun;42(6):705-714. doi: 10.1097/PAS.0000000000001059.

PMID:
29624511
5.

Adoption of Total Neoadjuvant Therapy for Locally Advanced Rectal Cancer.

Cercek A, Roxburgh CSD, Strombom P, Smith JJ, Temple LKF, Nash GM, Guillem JG, Paty PB, Yaeger R, Stadler ZK, Seier K, Gonen M, Segal NH, Reidy DL, Varghese A, Shia J, Vakiani E, Wu AJ, Crane CH, Gollub MJ, Garcia-Aguilar J, Saltz LB, Weiser MR.

JAMA Oncol. 2018 Jun 14;4(6):e180071. doi: 10.1001/jamaoncol.2018.0071. Epub 2018 Jun 14.

PMID:
29566109
6.

Association of Preoperative and Postoperative Serum Carcinoembryonic Antigen and Colon Cancer Outcome.

Konishi T, Shimada Y, Hsu M, Tufts L, Jimenez-Rodriguez R, Cercek A, Yaeger R, Saltz L, Smith JJ, Nash GM, Guillem JG, Paty PB, Garcia-Aguilar J, Gonen M, Weiser MR.

JAMA Oncol. 2018 Mar 1;4(3):309-315. doi: 10.1001/jamaoncol.2017.4420.

PMID:
29270608
7.

Rectal Gastrointestinal Stromal Tumor (GIST) in the Era of Imatinib: Organ Preservation and Improved Oncologic Outcome.

Cavnar MJ, Wang L, Balachandran VP, Antonescu CR, Tap WD, Keohan M, Singer S, Temple L, Nash GM, Weiser MR, Guillem JG, Aguilar JG, DeMatteo RP, Paty PB.

Ann Surg Oncol. 2017 Dec;24(13):3972-3980. doi: 10.1245/s10434-017-6087-9. Epub 2017 Oct 20.

PMID:
29058144
8.

Logarithmic expansion of LGR5+ cells in human colorectal cancer.

Martin ML, Zeng Z, Adileh M, Jacobo A, Li C, Vakiani E, Hua G, Zhang L, Haimovitz-Friedman A, Fuks Z, Kolesnick R, Paty PB.

Cell Signal. 2018 Jan;42:97-105. doi: 10.1016/j.cellsig.2017.09.018. Epub 2017 Sep 25.

PMID:
28958617
9.

The incidence and fate of endoleaks vary between ruptured and elective endovascular abdominal aortic aneurysm repair.

Quinn AA, Mehta M, Teymouri MJ, Keenan ME, Paty PSK, Zhou Y, Chang BB, Feustel P.

J Vasc Surg. 2017 Jun;65(6):1617-1624. doi: 10.1016/j.jvs.2016.10.092. Epub 2017 Mar 6.

PMID:
28268109
10.

Distinct Levels of Radioresistance in Lgr5+ Colonic Epithelial Stem Cells versus Lgr5+ Small Intestinal Stem Cells.

Hua G, Wang C, Pan Y, Zeng Z, Lee SG, Martin ML, Haimovitz-Friedman A, Fuks Z, Paty PB, Kolesnick R.

Cancer Res. 2017 Apr 15;77(8):2124-2133. doi: 10.1158/0008-5472.CAN-15-2870. Epub 2017 Feb 15.

11.

EGFR Gene Amplification and KRAS Mutation Predict Response to Combination Targeted Therapy in Metastatic Colorectal Cancer.

Khan SA, Zeng Z, Shia J, Paty PB.

Pathol Oncol Res. 2017 Jul;23(3):673-677. doi: 10.1007/s12253-016-0166-2. Epub 2016 Dec 26.

12.

Clinical and genetic determinants of ovarian metastases from colorectal cancer.

Ganesh K, Shah RH, Vakiani E, Nash GM, Skottowe HP, Yaeger R, Cercek A, Lincoln A, Tran C, Segal NH, Reidy DL, Varghese A, Epstein AS, Sonoda Y, Chi D, Guillem J, Temple L, Paty P, Hechtman J, Shia J, Weiser M, Aguilar JG, Kemeny N, Berger MF, Saltz L, Stadler ZK.

Cancer. 2017 Apr 1;123(7):1134-1143. doi: 10.1002/cncr.30424. Epub 2016 Nov 22.

13.

Developing a robotic colorectal cancer surgery program: understanding institutional and individual learning curves.

Guend H, Widmar M, Patel S, Nash GM, Paty PB, Guillem JG, Temple LK, Garcia-Aguilar J, Weiser MR.

Surg Endosc. 2017 Jul;31(7):2820-2828. doi: 10.1007/s00464-016-5292-0. Epub 2016 Nov 4.

14.

Distance to the anal verge is associated with pathologic complete response to neoadjuvant therapy in locally advanced rectal cancer.

Patel SV, Roxburgh CS, Vakiani E, Shia J, Smith JJ, Temple LK, Paty P, Garcia-Aguilar J, Nash G, Guillem J, Wu A, Reyngold M, Weiser MR.

J Surg Oncol. 2016 Oct;114(5):637-641. doi: 10.1002/jso.24358. Epub 2016 Sep 19.

15.

Percutaneous common femoral artery interventions using angioplasty, atherectomy, and stenting.

Mehta M, Zhou Y, Paty PS, Teymouri M, Jafree K, Bakhtawar H, Hnath J, Feustel P.

J Vasc Surg. 2016 Aug;64(2):369-379. doi: 10.1016/j.jvs.2016.03.418.

16.

Colorectal cancer in the very young: a comparative study of tumor markers, pathology and survival in early onset and adult onset patients.

Khan SA, Morris M, Idrees K, Gimbel MI, Rosenberg S, Zeng Z, Li F, Gan G, Shia J, LaQuaglia MP, Paty PB.

J Pediatr Surg. 2016 Nov;51(11):1812-1817. doi: 10.1016/j.jpedsurg.2016.07.015. Epub 2016 Aug 5.

17.

Incisional hernias after laparoscopic and robotic right colectomy.

Widmar M, Keskin M, Beltran P, Nash GM, Guillem JG, Temple LK, Paty PB, Weiser MR, Garcia-Aguilar J.

Hernia. 2016 Oct;20(5):723-8. doi: 10.1007/s10029-016-1518-2. Epub 2016 Jul 28.

18.

Long-term oncologic outcomes for simultaneous resection of synchronous metastatic liver and primary colorectal cancer.

Silberhumer GR, Paty PB, Denton B, Guillem J, Gonen M, Araujo RLC, Nash GM, Temple LK, Allen PJ, DeMatteo RP, Weiser MR, Wong WD, Jarnagin WR, D'Angelica MI, Fong Y.

Surgery. 2016 Jul;160(1):67-73. doi: 10.1016/j.surg.2016.02.029. Epub 2016 Apr 11.

19.

PKLR promotes colorectal cancer liver colonization through induction of glutathione synthesis.

Nguyen A, Loo JM, Mital R, Weinberg EM, Man FY, Zeng Z, Paty PB, Saltz L, Janjigian YY, de Stanchina E, Tavazoie SF.

J Clin Invest. 2016 Feb;126(2):681-94. doi: 10.1172/JCI83587. Epub 2016 Jan 19.

20.

Oncogenic KRAS activates an embryonic stem cell-like program in human colon cancer initiation.

Le Rolle AF, Chiu TK, Zeng Z, Shia J, Weiser MR, Paty PB, Chiu VK.

Oncotarget. 2016 Jan 19;7(3):2159-74. doi: 10.18632/oncotarget.6818.

21.
22.

Free Jejunal Flap for Pharyngoesophageal Reconstruction in Head and Neck Cancer Patients: An Evaluation of Donor-Site Complications.

Razdan SN, Albornoz CR, Matros E, Paty PB, Cordeiro PG.

J Reconstr Microsurg. 2015 Nov;31(9):643-6. doi: 10.1055/s-0035-1556872. Epub 2015 Jul 28.

23.

The prognostic significance of CXCL1 hypersecretion by human colorectal cancer epithelia and myofibroblasts.

le Rolle AF, Chiu TK, Fara M, Shia J, Zeng Z, Weiser MR, Paty PB, Chiu VK.

J Transl Med. 2015 Jun 24;13:199. doi: 10.1186/s12967-015-0555-4.

24.

Erratum to: Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review.

Nash GM, Smith JD, Cercek A, Tang L, Weiser MR, Temple LK, O'Reilly E, Saltz LB, Guillem JG, Paty PB.

Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1613. doi: 10.1245/s10434-015-4568-2. No abstract available.

PMID:
25862584
25.

Lymph Node Metastasis Predicts Disease Recurrence in a Single-Center Experience of 70 Stages 1-3 Appendix Cancers: A Retrospective Review.

Nash GM, Smith JD, Tang L, Weiser MR, Temple LK, O'Reilly E, Saltz LB, Guillem JG, Paty PB.

Ann Surg Oncol. 2015 Oct;22(11):3613-7. doi: 10.1245/s10434-015-4415-5. Epub 2015 Feb 7. Erratum in: Ann Surg Oncol. 2015 Dec;22 Suppl 3:S1613.

26.

Long-Term Survival After High-Dose-Rate Brachytherapy for Locally Advanced or Recurrent Colorectal Adenocarcinoma.

Terezakis S, Morikawa L, Wu A, Zhang Z, Shi W, Weiser MR, Paty PB, Guillem J, Temple L, Nash GM, Zelefsky MJ, Goodman KA.

Ann Surg Oncol. 2015 Jul;22(7):2168-78. doi: 10.1245/s10434-014-4271-8. Epub 2015 Jan 29.

27.

Simultaneous resection for rectal cancer with synchronous liver metastasis is a safe procedure.

Silberhumer GR, Paty PB, Temple LK, Araujo RL, Denton B, Gonen M, Nash GM, Allen PJ, DeMatteo RP, Guillem J, Weiser MR, D'Angelica MI, Jarnagin WR, Wong DW, Fong Y.

Am J Surg. 2015 Jun;209(6):935-42. doi: 10.1016/j.amjsurg.2014.09.024. Epub 2014 Dec 13.

28.

Extracellular metabolic energetics can promote cancer progression.

Loo JM, Scherl A, Nguyen A, Man FY, Weinberg E, Zeng Z, Saltz L, Paty PB, Tavazoie SF.

Cell. 2015 Jan 29;160(3):393-406. doi: 10.1016/j.cell.2014.12.018. Epub 2015 Jan 15.

29.

Does endoscopic ultrasound improve detection of locally recurrent anal squamous-cell cancer?

Peterson CY, Weiser MR, Paty PB, Guillem JG, Nash GM, Garcia-Aguilar J, Patil S, Temple LK.

Dis Colon Rectum. 2015 Feb;58(2):193-8. doi: 10.1097/DCR.0000000000000291.

30.

High incidence of LRAT promoter hypermethylation in colorectal cancer correlates with tumor stage.

Cheng YW, Pincas H, Huang J, Zachariah E, Zeng Z, Notterman DA, Paty P, Barany F.

Med Oncol. 2014 Nov;31(11):254. doi: 10.1007/s12032-014-0254-7. Epub 2014 Sep 27.

31.

Comparison of tumor regression grade systems for locally advanced rectal cancer after multimodality treatment.

Trakarnsanga A, Gönen M, Shia J, Nash GM, Temple LK, Guillem JG, Paty PB, Goodman KA, Wu A, Gollub M, Segal N, Saltz L, Garcia-Aguilar J, Weiser MR.

J Natl Cancer Inst. 2014 Sep 22;106(10). pii: dju248. doi: 10.1093/jnci/dju248. Print 2014 Oct.

32.

Percutaneous Cryoablation for Local Control of Metachronous Inguinal Lymph Node Metastases.

Cornelis F, Paty PB, Sofocleous CT, Solomon SB, Durack JC.

Cardiovasc Intervent Radiol. 2015 Oct;38(5):1369-72. doi: 10.1007/s00270-014-0946-6. Epub 2014 Jul 1. No abstract available.

33.

Management and outcome of perianal Paget's disease: a 6-decade institutional experience.

Perez DR, Trakarnsanga A, Shia J, Nash GM, Temple LK, Paty PB, Guillem JG, Garcia-Aguilar J, Weiser MR.

Dis Colon Rectum. 2014 Jun;57(6):747-751. doi: 10.1097/DCR.0000000000000100.

34.

Neoadjuvant chemotherapy first, followed by chemoradiation and then surgery, in the management of locally advanced rectal cancer.

Cercek A, Goodman KA, Hajj C, Weisberger E, Segal NH, Reidy-Lagunes DL, Stadler ZK, Wu AJ, Weiser MR, Paty PB, Guillem JG, Nash GM, Temple LK, Garcia-Aguilar J, Saltz LB.

J Natl Compr Canc Netw. 2014 Apr;12(4):513-9.

35.

Standardized protocols enable stroke recognition and early treatment of carotid stenosis.

Paty PS, Bernardini GL, Mehta M, Feustel PJ, Desai K, Roddy SP, Darling RC 3rd.

J Vasc Surg. 2014 Jul;60(1):85-91. doi: 10.1016/j.jvs.2014.01.047. Epub 2014 Mar 21.

36.

Phase II trial of hepatic artery infusional and systemic chemotherapy for patients with unresectable hepatic metastases from colorectal cancer: conversion to resection and long-term outcomes.

DʼAngelica MI, Correa-Gallego C, Paty PB, Cercek A, Gewirtz AN, Chou JF, Capanu M, Kingham TP, Fong Y, DeMatteo RP, Allen PJ, Jarnagin WR, Kemeny N.

Ann Surg. 2015 Feb;261(2):353-60. doi: 10.1097/SLA.0000000000000614.

37.

Neoadjuvant radiation therapy prior to total mesorectal excision for rectal cancer is not associated with postoperative complications using current techniques.

Milgrom SA, Goodman KA, Nash GM, Paty PB, Guillem JG, Temple LK, Weiser MR, Garcia-Aguilar J.

Ann Surg Oncol. 2014 Jul;21(7):2295-302. doi: 10.1245/s10434-014-3624-7. Epub 2014 Mar 7.

38.

Neoadjuvant chemotherapy without routine use of radiation therapy for patients with locally advanced rectal cancer: a pilot trial.

Schrag D, Weiser MR, Goodman KA, Gonen M, Hollywood E, Cercek A, Reidy-Lagunes DL, Gollub MJ, Shia J, Guillem JG, Temple LK, Paty PB, Saltz LB.

J Clin Oncol. 2014 Feb 20;32(6):513-8. doi: 10.1200/JCO.2013.51.7904. Epub 2014 Jan 13.

39.

Angiographic identification of extrahepatic perfusion after hepatic arterial pump placement: implications for surgical prevention.

Perez DR, Kemeny NE, Brown KT, Gewirtz AN, Paty PB, Jarnagin WR, D'Angelica MI.

HPB (Oxford). 2014 Aug;16(8):744-8. doi: 10.1111/hpb.12208. Epub 2013 Dec 18.

40.

Management of recurrent rectal cancer: practical insights in planning and surgical intervention.

Yeo HL, Paty PB.

J Surg Oncol. 2014 Jan;109(1):47-52. doi: 10.1002/jso.23457. Epub 2013 Oct 10. Review.

PMID:
24122817
41.

Prognostic aspects of DCE-MRI in recurrent rectal cancer.

Gollub MJ, Cao K, Gultekin DH, Kuk D, Gonen M, Sohn M, Schwartz LH, Weiser MR, Temple LK, Nash GM, Guillem JG, Wang M, Garcia-Aguilar J, Goodman K, Paty PB.

Eur Radiol. 2013 Dec;23(12):3336-44. doi: 10.1007/s00330-013-2984-x. Epub 2013 Aug 27.

PMID:
23979104
42.

Conversion to complete resection and/or ablation using hepatic artery infusional chemotherapy in patients with unresectable liver metastases from colorectal cancer: a decade of experience at a single institution.

Ammori JB, Kemeny NE, Fong Y, Cercek A, Dematteo RP, Allen PJ, Kingham TP, Gonen M, Paty PB, Jarnagin WR, D'Angelica MI.

Ann Surg Oncol. 2013 Sep;20(9):2901-7. doi: 10.1245/s10434-013-3009-3. Epub 2013 Jun 15.

PMID:
23771246
43.

Intensity-modulated radiotherapy vs. conventional radiotherapy in the treatment of anal squamous cell carcinoma: a propensity score analysis.

Dasgupta T, Rothenstein D, Chou JF, Zhang Z, Wright JL, Saltz LB, Temple LK, Paty PB, Weiser MR, Guillem JG, Nash GM, Goodman KA.

Radiother Oncol. 2013 May;107(2):189-94. doi: 10.1016/j.radonc.2013.03.012. Epub 2013 May 18.

PMID:
23692961
44.

Does Palmaz XL stent deployment for type 1 endoleak during elective or emergency endovascular aneurysm repair predict poor outcome? A multivariate analysis of 1470 patients.

Byrne J, Mehta M, Dominguez I, Paty PS, Roddy SP, Feustel P, Sternbach Y, Darling RC.

Ann Vasc Surg. 2013 May;27(4):401-11. doi: 10.1016/j.avsg.2012.10.007. Epub 2013 Mar 26.

PMID:
23540671
45.

The impact of hemodynamic status on outcomes of endovascular abdominal aortic aneurysm repair for rupture.

Mehta M, Paty PS, Byrne J, Roddy SP, Taggert JB, Sternbach Y, Ozsvath KJ, Darling RC 3rd.

J Vasc Surg. 2013 May;57(5):1255-60. doi: 10.1016/j.jvs.2012.11.042. Epub 2013 Feb 4.

46.

Anastomotic leak following low anterior resection in stage IV rectal cancer is associated with poor survival.

Smith JD, Butte JM, Weiser MR, D'Angelica MI, Paty PB, Temple LK, Guillem JG, Jarnagin WR, Nash GM.

Ann Surg Oncol. 2013 Aug;20(8):2641-6. doi: 10.1245/s10434-012-2854-9. Epub 2013 Feb 6.

PMID:
23385965
47.

Recurrent somatic mutation of FAT1 in multiple human cancers leads to aberrant Wnt activation.

Morris LG, Kaufman AM, Gong Y, Ramaswami D, Walsh LA, Turcan Ş, Eng S, Kannan K, Zou Y, Peng L, Banuchi VE, Paty P, Zeng Z, Vakiani E, Solit D, Singh B, Ganly I, Liau L, Cloughesy TC, Mischel PS, Mellinghoff IK, Chan TA.

Nat Genet. 2013 Mar;45(3):253-61. doi: 10.1038/ng.2538. Epub 2013 Jan 27.

48.

Locoregional lymphadenectomy in the surgical management of anorectal melanoma.

Perez DR, Trakarnsanga A, Shia J, Nash GM, Temple LK, Paty PB, Guillem JG, Garcia-Aguilar J, Bello D, Ariyan C, Carvajal RD, Weiser MR.

Ann Surg Oncol. 2013 Jul;20(7):2339-44. doi: 10.1245/s10434-012-2812-6. Epub 2013 Jan 18.

49.

What is the significance of the circumferential margin in locally advanced rectal cancer after neoadjuvant chemoradiotherapy?

Trakarnsanga A, Gonen M, Shia J, Goodman KA, Nash GM, Temple LK, Guillem JG, Paty PB, Garcia-Aguilar J, Weiser MR.

Ann Surg Oncol. 2013 Apr;20(4):1179-84. doi: 10.1245/s10434-012-2722-7. Epub 2013 Jan 18.

50.

Endovascular repair of ruptured infrarenal abdominal aortic aneurysm is associated with lower 30-day mortality and better 5-year survival rates than open surgical repair.

Mehta M, Byrne J, Darling RC 3rd, Paty PS, Roddy SP, Kreienberg PB, Taggert JB, Feustel P.

J Vasc Surg. 2013 Feb;57(2):368-75. doi: 10.1016/j.jvs.2012.09.003. Epub 2012 Dec 21.

Supplemental Content

Support Center